Innovation News

Harnessing the power of the genetic code to treat human disease.

AGTC is developing cures for rare lung and eye diseases, offering hope to patients with unmet medical needs. With a highly specialized team of physicians and researchers, we use cutting-edge techniques to develop treatments for patients that have diseases caused by broken genes. We use gene therapy, which replaces those broken genes with normal functional genes, allowing a patient’s own body to produce proteins to treat their illness. A single injection provides long-lasting treatment, leading to a better quality of life for patients worldwide.

Our Team

Industry-leading experts and innovative thinkers merge to create a powerful force of teamwork and solutions at AGTC. We invite you to learn more about our team.

Meet the Team

Sue Washer

Dr. Jeffrey Chulay

Daniel L. Menichella

Larry Bullock

Tavara K. Andrews

David R. Knop, Ph. D.

Dr. Guo-jie Ye

Frank Sprecher